Breast cancer screening follow-up for moderate-risk women
Part of Cancer, Skin clinical trials.
This study looks at how well women with a moderate risk of breast cancer follow their screening recommendations (like yearly MRI or mammogram). It may help women who have certain genetic variants or a higher calculated risk stay on top of their breast health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 30 and 75 years old.
- You have either a moderate-risk genetic change (like in ATM, CHEK2, BARD1, RAD51C, or RAD51D) or a lifetime breast cancer risk of 20% to 40% as calculated by a special risk model.
- You received a breast cancer risk assessment from a genetic counselor at USC Norris or LA General Hospital in 2021 or later, and it's been at least 12 months since then.
- Your doctor recommended that you have a yearly breast MRI or mammogram (or both) starting around the time of your genetic counseling.
- You speak English or Spanish.
- You have never had breast cancer before your genetic counseling visit, and you have not had both breasts removed for risk reduction before your counseling.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how environmental exposures might affect breast cancer risk. It includes women at average risk, high risk, or those diagnosed with breast cancer before age 50, as well as healthcare providers.
This study tests a more thorough breast cancer screening program using MRI and other imaging for women at high risk. It aims to detect cancer earlier, which may improve treatment options and outcomes.
This study sets up a registry to help health teams choose the right screening tests for women based on individual risk. It may help participants by making screening more targeted, and it involves questionnaires and sometimes technology-based participation.
This study tests a decision aid to help women at high risk for breast cancer decide whether to get a screening MRI. It is designed for Black and Latina women who have had a normal mammogram in the past year.
This study looks at how to decide the best breast cancer screening (like mammograms) based on your personal risk. It may help by testing a smarter way to match screening to your risk level.
This study is testing a new way to use your genetic information (along with your family history) to better understand your personal risk for breast cancer. The goal is to see if giving this risk report to women with higher genetic risk can help them and their doctors make more informed decisions about screening and prevention.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.